Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products - A consequence of inappropriate nomenclature and imprecise labelling?

Clinical Toxicology

Volumn 44, Issue 4, 2006, Pages 371-378

  Cheung, Thomas ^a   Xue, Charlie ^a   Leung, Kelvin ^b   Chan, Kelvin ^b   Li, Chun ^a  

^a RMIT UNIVERSITY   (Australia)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Aristolochic acid; Chinese herbs; Herbal medicine toxicity; Traditional Chinese medicine

Indexed keywords

ANTIRHEUMATIC AGENT; ARISTOLOCHIC ACID; CHINESE DRUG; DIURETIC AGENT; HERBACEOUS AGENT; LAXATIVE;

ARISTOLOCHIA; ARTICLE; AUSTRALIA; CHINESE HERB; CHINESE MEDICINE; DRUG LABELING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DISEASE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NOMENCLATURE; OBESITY; STEPHANIA; UROGENITAL TRACT TUMOR; WEIGHT CONTROL;

ARISTOLOCHIC ACIDS; DRUG LABELING; DRUGS, CHINESE HERBAL; PLANTS, MEDICINAL; TERMINOLOGY;

ANIMALIA; ARISTOLOCHIA;

EID: 33745685590     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650600671712     Document Type: Article

References (16)

1. Vanherweghem JL. A new form of nephropathy secondary to the absorption of Chinese herbs. Bull Mem Acad R Med Belg 1994; 149:128-135.
2. van Ypersele de Strihou C, Vanherweghem JL. The tragic paradigm of Chinese herbs nephropathy. Nephrol Dial Transplant 1995; 10:157-160.
3. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354:481-482.
4. Hashimoto K, Higuchi M, Makino B, Sakakibara I, Kubo M, Komatsu Y, Maruno M, Okada M. Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol 1999; 64:185-189.
5. Lee TY, Wu ML, Deng JF, Hwang DF. High-performance liquid chromatographic determination for aristolochic acid in medicinal plants and slimming products. J Chromatography B 2001; 799:169-174.
6. Gillerot G, Jadoul M, Arlt VM, et al. Aristolochic acid nephropathy in a Chinese patient: time to abandon the term Chinese herbs nephropathy? Am J Kidney Dis 2001; 38:E26.
7. Tanaka A, Nishida R, Yoshida T, Koshikawa M, Goto M, Kuwahara T. Outbreak of Chinese herbs nephropathy in Japan: are they different from Belgium? Intern Med 2001; 40:296-300.
8. Chen W, Chen Y, Li A. The clinical and pathological manifestations of aristolochic acid nephropathy: the report of 58 cases. Zhonghua Yi Xue Za Zhi 2001; 81:1101-5.
9. FDA website at http://www.fda.gov/ora/fiars/ora_import_ia5410.html. Accessed 27 March 2004.
10. Therapeutic Goods Administration of Australia website at http://www.health.gov.au/tga/docs.arialert.htm. Accessed 5 August 2004.
11. Advanced Textbook on Traditional Chinese Medicine & Pharmacology. State Administration of TCM: New World Press, 1995.
12. Flurer RA, Jones MB, Vela N, Ciolino LA, Wolnik KA. Determination of aristolochic acid in traditional Chinese medicines and dietary supplements. FDA laboratory Information Bulletin #4212, 16: No 7, 1-13.
13. Encyclopaedia of Chinese Materia Medica (Chinese title: Zhong Yao Da Ci Dian). Ed. Jiangsu Xin Yi Xue Yuan. Shanghai Science and Technology Press, 1986:357-359, 981-985.
14. Pharmacopeia of The People's Republic of China. Published by the Chemical Industry Press. English edition, 1997.
15. Schaneberg BT, Applequist WL, Khan IA. Determination of aristolochic acid I and II in North American species of Asarum and Aristolochia. Pharmazie 2002; 57:686-689.
16. Australian government responsed to recommendations by the Therapeutic Goods Administration of Australia at http://www.tga.gov.au/cm/cmresponse.htm. Accessed 4 July 2005.